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Abstract 
Background and Aim: Asthma is an inflammatory airway disease and allergies are the most important cause of 
asthma. Different types of drugs have been developed to control asthma, and the use of carrier systems to transfer 
drugs to the airways is an effective method. Gold nanoparticles (AuNP) is a subject of substantial research that can 
be easily synthesized and, in this study, the effect of gold nanoparticles on allergic asthma was evaluated. 
Methods: There are 4 groups of mice, including: the control group, the control group receiving AuNPs, the asthmatic 
group, and the asthmatic group receiving AuNPs. An animal model of asthma was produced using ovalbumin (OVA). 
The negative control group was sensitized and challenged with PBS. Broncho-alveolar lavage fluid (BALF) and lung 
tissue were collected, then quantitative real-time PCR for the four target genes (IL-4, IL-5, IL-13, and MUC5ac) and 
histopathological study of lung tissue was done. 
Results: In the OVA group, the mRNA expression of targeted genes had no significant differences (P>0.05). Mucus 
hypersecretion, goblet cell hyperplasia, peribronchial and perivascular inflammation had no significant difference 
between AuNPs receiving groups with non-treated groups (P>0.05). 
Conclusion: In this study, it was observed that AuNP did not affect asthma and control mice. These nanoparticles 
did not elicit any immune or allergic responses and can be easily used for therapeutic or diagnostic purposes. 
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Introduction 
Asthma is an inflammatory respiratory tract disease 
of the airways with a prevalence of 7 to 35% and 
allergies are the most important cause of asthma. 
Inflammation and asthma-induced spasm in the 
bronchi, obstruct the airways in the lungs. Different 
types of drugs have been developed to treat and 
control asthma, and today it is trying to use 
nanomaterials for the therapeutic approach of 
asthma to have the higher possible effect on the 
target tissue with the lower dosage of the drug. 
Therefore, the use of carrier systems to transfer the 
desired material to the airways is an effective and 
practical method. The most important of these 
materials are designed for drug delivery 
nanoparticles (1, 2). 
AuNPs are a subject of substantial research because 
of their potential applications in a wide area variety 
including electronics, nanotechnology, and 
biomedicine. It can be easily synthesized using 
various techniques and also, can be simply attached 
with several molecules, such as nucleic acid, 
protein, carbohydrate, and lipid (3).  
The difference in the size of AuNP leads to different 
optical properties that can increase the wide use in 
modern biomedical applications (1, 4). 
Functionalized AuNPs have recently emerged as an 
attractive delivery carrier into targeted tissues. 
AuNPs can be conjugated to some specific 
molecules such as antibodies and aptamers for dual-
use, as diagnostic and therapeutic functionalized 
nanoparticles and prospectively can be used alone. 
Therefore, after the synthesis of considered AuNP, 
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the effect of this nanoparticles on allergic asthma 
was evaluated. 
Methods 
Animals and experiment 
Female BALB/c mice were purchased at 6 weeks of 
age (from Pasteur Institute of Iran) and kept under 
standard laboratory conditions (temperature 
24±2°C; humidity 60±5%; and 12 h light-dark 
cycles). In the tests, 4 groups of mice of the same 
gender, same breed, and the same age were 
considered (each group consisted of 10 mice, that 
5 mice were used to obtain lung tissue and the other 
5 mice in each group were used to a sampling of 
BALF). Prior to the experiments, the mice were kept 
for two weeks to adapt to the new environment . 
Animal treatment protocol 
The 4 groups including: control group, the control 
group receiving AuNPs (the average diameter: 100-
200 nm, Zeta potent Z-average: 137.9 d.nm) on day 
23, 25, 27, and 29 (inhalation for 30 min per day), 
asthmatic group, the asthmatic group receiving 
AuNPs on day 23, 25, 27 and 29 (inhalation for 30 
min per day). An animal model of asthma was 
produced using OVA according to Athari et al., 
2016 (1). In brief, the mice were sensitized by 20 μg 
of OVA with 50 μL Alum adjuvant via 
intraperitoneal injection (IP) on days 1 and 14. Then 
challenged by 1% OVA solution aerosolized by an 
ultrasonic nebulizer via inhalation (IT) for 30 min 
per day on days 24, 26, 28, and 30 (Figure 1). The 
negative control group was sensitized and 
challenged with PBS. BALF and lung tissue were 
collected 1 day after the last challenge (day 31). 
In all procedures we followed ethical guidelines. 
Animals were killed humanely using CO2 gas and 
then sampling was done. 
Quantitative Real-Time PCR 
Total RNA was isolated from BALF cells according 
to the manufacturer's instructions (1). Extracted 
RNA was reverse transcribed to cDNA using a 
cDNA synthesis kit (Maxima First Strand cDNA 
Synthesis Kit, Thermo Scientific, USA). 
Quantitative PCR analysis was performed. Primers 
for the four target genes (IL-4, IL-5, IL-13, and 
MUC5ac) and one primer-pair for GAPDH are 
shown in Table 1. 
 
 
Figure 1. Sensitization, challenge, and treatment program in the studied groups. IP of OVA with alum adjuvant was 
performed on days 1 and 14 and also, OVA via IT was administered on days 24, 26, 28, and 30. Cases were treated on 
days 23, 25, 27, and 29 . 
 
Table 1. Used primers sequences 
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Histopathological study 
Mice lungs were isolated and tissue sections were 
stained with hematoxylin and eosin (H&E) stain. The 
ratio of mucus production, the goblet cell 
hyperplasia, peribronchial and perivascular 
inflammation was studied (1). 
Statistical analysis 
Experimental results are shown as means ± S.D. 
Results were compared in all pairs of groups or two-
tailed, student's t-test. Results were considered 
statistically significant when p < 0.05. 
Results 
Effects of gold nanoparticles on cytokines and 
mucin mRNA 
In the AuNPs receiving OVA group, the mRNA 
expression of IL-4 (7.01±1.44) and IL-5 (2.69±0.19) 
was decreased compared non-treated OVA group 
(IL-4: 8.11±1.37 and IL-5: 3.12± 0.22), but these 
decreasing were not significant (p >0.05). there is no 
significant difference between the control group and 
nanoparticles receiving control group for gene 
expression of IL-4, IL-5, IL-13, and mucin and also, 
between the OVA group and nanoparticles receiving 
OVA group for mucin gene expression (p >0.05) 
(Figure 2). IL-13 gene expression increased 
significantly in nanoparticles receiving OVA group 
(2.97±0.22) compared to OVA group (p <0.05) 
(2.01±0.13). 
Effects of gold nanoparticles on lung 
histopathology 
Mucus hypersecretion, goblet cell hyperplasia, and 
peribronchial inflammation had no significant 
difference between AuNPs receiving control group 
and control group, and also between, nanoparticles 
receiving OVA group and OVA group (p>0.05) 
(Figure 3). Perivascular inflammation was increased 
in the airway of OVA-challenged mice that received 
AuNPs (3.70±0.20), compared with the OVA group 
(3.40±0.10) and also, inflammation in the 
perivascular was increased in control mice that 
received gold nanoparticles (0.60±0.40), compared 
with the non-treated control group (0.50±0.10) (Fig. 
3), but these increases were not statistically 




Figure 2. The gene expression of cytokines, IL-4 (2a), IL-5 (2b), IL-13 (2c), and mucin [MUC5ac (2d)] were shown. 
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Figure 3. Lung histopathological sections in all groups were shown and study of mucus hyper-secretion (3a), goblet cell 
hyperplasia (3b), perivascular inflammation (3c), and peribronchial inflammation (3d) were presented. 
 
Discussion 
In this study, it was observed that AuNPs with 
described characteristics do not affect allergic 
asthma and control mice. It would be a beneficial 
factor for any studies that AuNPs will use as a drug 
delivery system for control and treatment of asthma 
without any changes in results of targeted drug 
effect. 
However, small-sized AuNPs (under 50 nm) have 
shown considerable antimicrobial activity. The 
antibacterial activity of the AuNPs can be attributed 
to the reactive oxygen species (ROS) generation that 
intensifies the oxidative stress of microbial cells (5, 
6). But in asthma, ROS is a dangerous factor in the 
pathophysiology of asthma (7) and increased levels 
of ROS would lead to an increased asthma attack. 
Therefore, these produced AuNPs are not suitable to 
use as drug delivery or carrier for control and 
treatment of asthma. Because this component can 
increase asthma severity and reduce the effect of 
used drugs or treatments.  
On the other hand, AuNPs are used as signal 
amplifiers to detect some diagnostic factors and 
hazardous toxins in immunosensor system of flow-
type. It can be done by a collaboration of antibodies 
or other specific molecules such as modified 
mannose, functionalized aptamer, etc. Also, 
antibody-conjugated nanoparticles can be used for 
tissue and cellular imaging using a confocal 
reflectance microscope. Immune-labeled 
nanoparticles are used for the monitoring of diseases 
(8, 9). AuNPs have several advantages for cellular 
imaging. They scatter light intensity and brightness 
is much than chemical fluorophores. They do not 
have to photobleach and can be easily detected in as 
low as 10−16 M concentration. Due to AuNPs can 
resonantly scatter visible light and also NIR 
radiations upon excitation of their surface plasmon 
oscillation. This property can be used for 
intracellular trafficking of AuNPs as contrast agents 
in the dark field of optical microscopy (8-10).  
The most important criterion for gene delivery 
system is escaping from the reticuloendothelial 
clearance system, and not elicits an immune response 
against the gene (11). AuNPs do not elicit any 
immune or allergic responses, and can be easily used 
for therapeutic (carrier of drugs) or diagnostic 
(nanoprobe) purposes. 
Conclusion 
In this study, we observed that AuNPs in 100-
200 nm size are suitable particles as drug delivery 
systems to the airway and when it will be necessary 
to use drug carriers, it may be an effective carrier for 
the anti-asthma drugs. This can be used in the design 
and production of new anti-asthma drugs.  
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